{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T22:20:27Z","timestamp":1649110827180},"posted":{"date-parts":[[2018,8,12]]},"reference-count":0,"publisher":"Morressier","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.26226\/morressier.5b3b802db1b87b000eced9e8","type":"posted-content","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T16:51:42Z","timestamp":1582131102000},"source":"Crossref","is-referenced-by-count":0,"title":["08 \/ ASSESSMENT OF SYMPTOM BURDEN AMONG PATIENTS DIAGNOSED WITH MULTIPLE MYELOMA (MM) ADMITTED TO RECEIVE CHEMOTHERAPY AT THE INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA (IORS)"],"prefix":"10.26226","author":[{"given":"Djordjevic","family":"Fedja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22980","container-title":[],"original-title":[],"deposited":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T17:13:16Z","timestamp":1582132396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.morressier.com\/article\/5b3b802db1b87b000eced9e8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,12]]},"references-count":0,"URL":"https:\/\/doi.org\/10.26226\/morressier.5b3b802db1b87b000eced9e8","relation":{},"subject":[],"published":{"date-parts":[[2018,8,12]]},"subtype":"other"}}